Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Cash generated from core business operations
3Y CAGR
+187.5%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
23.8x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $137.99M | +437.1% |
| 2024 | $25.69M | +93.1% |
| 2023 | $13.30M | +129.1% |
| 2022 | $5.81M | +104.6% |
| 2021 | $-126.30M | +7.5% |
| 2020 | $-136.53M | +13.8% |
| 2019 | $-158.37M | -95.5% |
| 2018 | $-81.01M | -61.3% |
| 2017 | $-50.22M | -129.7% |
| 2016 | $-21.87M | - |